USDC ND CA — Post Trial Briefing Schedule Extended: Gilead Vs. Merck — On Amount Of Legal Fees & Expenses Merck Will Have To pay To Gilead

mrk-gil-fees-10-2016 We have long covered this portion of the bi-coastal US patent fights between Merck and Gilead — over the effects of some basic Merck Hep C sofosbivur patents — and the purported need for Gilead to license those patents, and pay a royalty to Kenilworth — in order to be able to sell Sovaldi® and Harvoni®, in the US.

The post trial briefing on how much of Gilead’s legal fees Merck will be ordred to pay has been stretched a bit — in an order just entered in San Jose, California — thus:

. . . .Oct. 14, 2016
| Oct. 28, 2016 | Gilead files opening brief regarding amount of fees award

Nov. 4, 2016 | Nov. 18, 2016 | Merck files opposition brief regarding amount of fees award

Nov. 18, 2016 | Dec. 2, 2016 | Gilead files reply brief regarding amount of fees award. . . .

And. . . Go Cubs GO — close out the Giants!

नमस्ते

Advertisements

There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: